Skip to main content
. 2022 Mar 17;6(6):1895–1903. doi: 10.1182/bloodadvances.2021006456

Figure 4.

Figure 4.

Clinical outcomes of male-to-male allo-HCT. (A) OS. (B) NRM. (C) CIR.